[Endocannabinoid system: new perspectives in the global management of cardiometabolic risk factors].
Maldonado
Rafael
R
Departamento de Ciencias Experimentales i de la Salud, Laboratorio de Neurofarmacología, Universitat Pompeu Fabra, Barcelona, España. rafael.maldonado@upf.edu
D000818:Animals; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism / Q000502:physiology*; D063388:Endocannabinoids; D004734:Energy Metabolism; D006321:Heart / Q000503:physiopathology*; D006331:Heart Diseases / Q000209:etiology* / Q000378:metabolism*; D006801:Humans; D009206:Myocardium / Q000378:metabolism*; D043884:Receptor, Cannabinoid, CB1 / Q000502:physiology; D012307:Risk Factors
D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D043884:Receptor, Cannabinoid, CB1